Treatment gap for anxiety disorders is global: Results of the World Mental Health Surveys in 21 countries.
Treatment gap for anxiety disorders is global: Results of the World Mental Health Surveys in 21 countries.
复制标题
DOI：
10.1002/da.22711
复制
发表时间：
2018-03
影响因子：
7.4
通讯作者：
WHO World Mental Health Survey Collaborators
中科院分区：
文献类型：
--
作者：
Alonso J;Liu Z;Evans-Lacko S;Sadikova E;Sampson N;Chatterji S;Abdulmalik J;Aguilar-Gaxiola S;Al-Hamzawi A;Andrade LH;Bruffaerts R;Cardoso G;Cia A;Florescu S;de Girolamo G;Gureje O;Haro JM;He Y;de Jonge P;Karam EG;Kawakami N;Kovess-Masfety V;Lee S;Levinson D;Medina-Mora ME;Navarro-Mateu F;Pennell BE;Piazza M;Posada-Villa J;Ten Have M;Zarkov Z;Kessler RC;Thornicroft G;WHO World Mental Health Survey Collaborators
焦虑症是疾病负担的主要原因。治疗差距已被描述，但缺乏一个全球性的评价。我们估计了21个国家中患有12个月DSM-IV焦虑症的个体中：i）认为需要治疗的比例; ii）接受任何治疗的比例;以及（iii）接受可能足够的治疗的比例。数据来自WMH调查中21个国家的24个社区调查。对精神障碍进行了DSM-IV评估（WHO复合国际诊断访谈，CIDI 3.0）。DSM-4将创伤后应激障碍纳入焦虑症，而DSM-5则不这样认为。我们询问，在过去的12个月里，受访者是否认为他们需要专业治疗，以及他们是否因“情绪，神经，心理健康或使用酒精或药物问题”而获得专业治疗（专业/普通医疗，补充替代医疗或非医疗专业）。可能充分的治疗定义为接受药物治疗（1个月以上的药物治疗和4次以上的医生就诊）或心理治疗、CAM或非医疗护理（8次以上的就诊）。在51，547名受访者中（响应=71.3%），9.8%的人患有12个月的DSM-IV焦虑症，其中27.6%的人接受了任何治疗，只有9.8%的人接受了可能适当的治疗。41.3%的焦虑12个月的人认为需要照顾。低收入国家的治疗水平较低。全世界都存在服务利用率低和接受服务的人中有很高比例不符合焦虑症的适当标准的情况。结果表明，需要提高认识的焦虑症和治疗质量。
Anxiety disorders are a major cause of burden of disease. Treatment gaps have been described, but a worldwide evaluation is lacking. We estimated, among individuals with a 12-month DSM-IV anxiety disorder in 21 countries, the proportion who: i) perceived a need for treatment; ii) received any treatment; and (iii) received possibly adequate treatment. Data from 24 community surveys in 21 countries of the WMH surveys. DSM-IV mental disorders were assessed (WHO Composite International Diagnostic Interview, CIDI 3.0). DSM-IV included PTSD among anxiety disorders, while it is not considered so in the DSM-5. We asked if, in the previous 12 months, respondents felt they needed professional treatment and if they obtained professional treatment (specialized/general medical, complementary alternative medical, or non-medical professional) for “problems with emotions, nerves, mental health, or use of alcohol or drugs”. Possibly adequate treatment was defined as receiving pharmacotherapy (1+ months of medication and 4+ visits to a medical doctor) or psychotherapy, CAM or non-medical care (8+ visits). Of 51,547 respondents (response=71.3%), 9.8% had a 12-month DSM-IV anxiety disorder, 27.6% of whom received any treatment, and only 9.8% received possibly adequate treatment. 41.3% of those with 12-month anxiety perceived a need for care. Lower treatment levels were found for lower income countries. Low levels of service use and a high proportion of those receiving services not meeting adequacy standards for anxiety disorders exist worldwide. Results suggest the need for improving recognition of anxiety disorders and the quality of treatment.
登录
查看更多内容
影响因子：
120.7
作者：
Demyttenaere, K;Bruffaerts, R;Chatterji, S
通讯作者：
Chatterji, S
影响因子：
64.3
作者：
Chisholm, Dan;Sweeny, Kim;Saxena, Shekhar
通讯作者：
Saxena, Shekhar
影响因子：
7.4
作者：
Haemaelaeinen, J.;Isometsae, E.;Kiviruusu, O.
通讯作者：
Kiviruusu, O.
影响因子：
4.4
作者：
Ho, Ka Po;Hunt, Caroline;Li, Stephen
通讯作者：
Li, Stephen
DOI：
10.1007/s00406-003-0449-y
发表时间：
2003-12-01
影响因子：
4.7
作者：
H채rter, MC;Conway, KP;Merikangas, KR
通讯作者：
Merikangas, KR